ZTS

ZOETIS
D

ZTS

154.110
USD
1.04
(0.68%)
مغلق
حجم التداول
94,573
الربح لكل سهم
6
العائد الربحي
1.25
P/E
27
حجم السوق
68,299,004,870
التوصيات
Moustafa El khaldy
Moustafa El khaldy
منذ سنة
buy
ZTS
ZTS @174.98
2024-07-08 03:45
ZTS@174.98 Chart
الربح
-1,043.50
-11.93%
المزيد
أصول ذات صلة
AMGN
AMGN
6.28
(2.16%)
296.49 USD
BMRN
BMRN
-0.470
(-0.81%)
57.530 USD
E
ELAN
-0.045
(-0.25%)
17.950 USD
GILD
GILD
-0.680
(-0.57%)
118.320 USD
IDXX
IDXX
-3.00
(-0.46%)
650.79 USD
INCY
INCY
0.780
(0.91%)
86.940 USD
MRK
MRK
1.500
(1.81%)
84.250 USD
REGN
REGN
14.73
(2.60%)
580.63 USD
VRTX
VRTX
2.49
(0.64%)
392.97 USD
المزيد
الأخبار المقالات

العنوان: ZOETIS

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.